Thinly traded nano cap ThermoGenesis (NASDAQ:THMO) jumps 45% premarket on robust volume in reaction to its announcement that the FDA has agreed that its COVID-19 antibody blood test has been properly validated and can now be distributed.
It will co-market the test with ImmuneCyte Life Sciences.
https://seekingalpha.com/news/3561273-thermogenesis-on-go-to-distribute-covidminus-19-test-shares-up-45-premarket
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.